Karim Dabbagh

Health Technology

Consumer Services

Profile

Karim Dabbagh is the founder of Modus Biomedicine, Inc. which was founded in 2009.
He held the title of Chief Executive Officer from 2009 to 2010.
Dr. Dabbagh is currently the Independent Chairman at Maat Pharma SA since 2023.
Previously, he worked at Second Genome, Inc. from 2014 to 2023, where he held the titles of President, Chief Executive Officer & Director from 2018 to 2023.
Dr. Dabbagh completed his undergraduate degree at Imperial College London and his doctorate at University College London.

Karim Dabbagh active positions

Companies	Position	Start
MAAT PHARMA	Chairman	2023-06-20

All active positions of Karim Dabbagh

Former positions of Karim Dabbagh

Companies	Position	End
Second Genome, Inc. Second Genome, Inc. BiotechnologyHealth Technology Second Genome, Inc. develops microbiome-based therapeutic products. It offers phyclochip community, 16S sequencing community analysis, whole metagenomic profiling, nucleic acid isolation, inferred function and custom informatics services. The company was founded in 2009 by Corey S. Goodman, Janet A. Warrington, Todd Z. DeSantis, John Hulls and Gary Andersen and is headquartered in South San Francisco, CA.	Chief Executive Officer	2023-08-31
Modus Biomedicine, Inc.	Chief Executive Officer	2010-11-30

See the detail of Karim Dabbagh's experience

Training of Karim Dabbagh

University College London	Doctorate Degree
Imperial College London	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Karim Dabbagh's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
MAAT PHARMA	Health Technology

Private companies	2
Second Genome, Inc. Second Genome, Inc. BiotechnologyHealth Technology Second Genome, Inc. develops microbiome-based therapeutic products. It offers phyclochip community, 16S sequencing community analysis, whole metagenomic profiling, nucleic acid isolation, inferred function and custom informatics services. The company was founded in 2009 by Corey S. Goodman, Janet A. Warrington, Todd Z. DeSantis, John Hulls and Gary Andersen and is headquartered in South San Francisco, CA.	Health Technology
Modus Biomedicine, Inc.